Goel, Harsh
Dunbar, Richard L.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K23HL091130)
Article History
First Online: 1 March 2016
Compliance with Ethical Standards
: Richard L. Dunbar declares NIH grant K23HL091130 (R.L. Dunbar) from the NHLBI. Dr. Dunbar also served as a local investigator for the AIM-HIGH study, overseeing 30 participants from the Philadelphia VA Medical Center and 14 from the University of Pennsylvania. Dr. Dunbar was a local investigator for a clinical trial of MK1903 funded by Merck & Co. and has received personal fees for consulting for Catabasis.
: Harsh Goel served as a sub-investigator for the AIM-HIGH study, assisting Dr. Dunbar.
: This article does not contain any studies with human or animal subjects performed by any of the authors.